Adrenal disease

Prevalence of adrenal rest tumors and course of gonadal dysfunction in a clinical sample of men with congenital adrenal hyperplasia: a longitudinal analysis over 10 years

Eur J EndocrinolPublished Retrospective longitudinal cohort study

Authors' conclusion

T levels below the normal range are frequent in men with 21OHD, regardless of TART, but change little over time. Besides adrenal androgen control gonadal axis suppression from supraphysiological glucocorticoid dosages needs to be considered. While our results do not endorse regular screening for alterations in TART status among adults, Sertoli cell function should be monitored in men with large TART.

Study context

Population
Men with classic 21-hydroxylase deficiency (21OHD); median observation period 12 years
Participants
27 men
Exposure
Men with TART vs without TART
  • TARTn = 11
Outcome
Long-term evolution of gonadal function (T, 11-oxygenated androgens, gonadotropins, inhibin B)
Follow-up
Median observation period 12 years
Methodological detailssingle-centre
  • Single-centre

Main finding

As reported in the abstract

T concentrations below the normal range, per patient

n.s.

Observational data: associations, not effects.

Further findings

T adjusted for BMI, SHBG and age

T adjusted for BMI, SHBG and age

Men with TART exhibited higher T than those without

T during observation period · start to end of observation

TART: T rose from 10.1 ± 1.1 to 17.3 ± 1.9 nmol/L
No TART: T rose from 10.3 ± 1.0 to 12.8 ± 1.9 nmol/L
  • Accompanied by rising LH

Hydrocortisone equivalent dosage during observation period · start to end of observation

TART: from 38.1 ± 3.2 to 35.1 ± 1.8 mg/d
No TART: from 28.8 ± 2.7 to 28.1 ± 1.6 mg/d
No correlation with any markers of adrenal androgen control

Inhibin B and TART status over time

Inhibin B declined in men with large TART over time; TART status remained stable

Original publication

Prevalence of adrenal rest tumors and course of gonadal dysfunction in a clinical sample of men with congenital adrenal hyperplasia: a longitudinal analysis over 10 years. Eur J Endocrinol. Published 23 September 2024. doi:10.1093/ejendo/lvae112

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.